Asclera
Active substance: polidocanol
INJECTION, SOLUTION · POLIDOCANOL .01 g/mL
United StatesActive
Marketing holder: Methapharm, Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- POLIDOCANOL · .01 g/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8409-77c8-bcfe-31421cbce6a2,01a1208c-9f9a-7dc9-ae23-d0d6ad855597,01a1208d-837b-70b4-8a66-2fff1bc79cb9,01a1208e-8fd9-7210-bac4-7a2dca0df3a2;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 67850-141
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 67850-141 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 67850-141 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 67850-141 · Verified 2026-10-09 · open in source